Format

Send to

Choose Destination
Nutr J. 2012 Nov 12;11:93. doi: 10.1186/1475-2891-11-93.

Comparison of menaquinone-4 and menaquinone-7 bioavailability in healthy women.

Author information

1
Fine Chemical Laboratory, J-OIL MILLS, INC, 1746 Nakashinden, Fukuroi-city, Shizuoka, 437-1111, Japan. toshiro.sato@j-oil.com

Abstract

BACKGROUND:

Vitamin K₂ contributes to bone and cardiovascular health. Therefore, two vitamin K₂ homologues, menaquinone-4 (MK-4) and menaquinone-7 (MK-7), have been used as nutrients by the food industry and as nutritional supplements to support bone and cardiovascular health. However, little is known about the bioavailability of nutritional MK-4. To investigate MK-4 and MK-7 bioavailability, nutritional doses were administered to healthy Japanese women.

FINDINGS:

Single dose administration of MK-4 (420 μg; 945 nmol) or MK-7 (420 μg; 647 nmol) was given in the morning together with standardized breakfast. MK-7 was well absorbed and reached maximal serum level at 6 h after intake and was detected up to 48 h after intake. MK-4 was not detectable in the serum of all subjects at any time point. Consecutive administration of MK-4 (60 μg; 135 nmol) or MK-7 (60 μg; 92 nmol) for 7 days demonstrated that MK-4 supplementation did not increase serum MK-4 levels. However, consecutive administration of MK-7 increased serum MK-7 levels significantly in all subjects.

CONCLUSIONS:

We conclude that MK-4 present in food does not contribute to the vitamin K status as measured by serum vitamin K levels. MK-7, however significantly increases serum MK-7 levels and therefore may be of particular importance for extrahepatic tissues.

PMID:
23140417
PMCID:
PMC3502319
DOI:
10.1186/1475-2891-11-93
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center